0001239241-13-000007.txt : 20130925
0001239241-13-000007.hdr.sgml : 20130925
20130925184810
ACCESSION NUMBER: 0001239241-13-000007
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130918
FILED AS OF DATE: 20130925
DATE AS OF CHANGE: 20130925
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCELERON PHARMA INC
CENTRAL INDEX KEY: 0001280600
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SYDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-9200
MAIL ADDRESS:
STREET 1: 128 SYDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EVNIN ANTHONY B
CENTRAL INDEX KEY: 0001239241
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36065
FILM NUMBER: 131115331
MAIL ADDRESS:
STREET 1: C/O VENROCK ASSOCIATES
STREET 2: 30 ROCKEFELLER PLAZA RM 5508
CITY: NEW YORK
STATE: NY
ZIP: 21264957
3/A
1
edgar.xml
PRIMARY DOCUMENT
X0206
3/A
2013-09-18
2013-09-18
0
0001280600
ACCELERON PHARMA INC
XLRN
0001239241
EVNIN ANTHONY B
C/O VENROCK
530 FIFTH AVENUE, 22ND FLOOR
NEW YORK
NY
10036
1
0
1
0
Series E Convertible Preferred Stock
Common Stock
118240
I
By Funds
The Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, Series D Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock are each convertible into Common Stock at any time at the holder's election and upon the consummation of a qualified public offering of the registrant. There is no expiration date for any series of convertible preferred stock.
Consists of an aggregate of 96,248 shares of Series E Convertible Preferred Stock ("Series E Stock") held by Venrock Associates IV, L.P. ("Venrock IV"), 19,628 shares of Series E Stock held by Venrock Partners, L.P. ("Venrock Partners"), and 2,364 shares of Series E Stock held by Venrock Entrepreneurs Fund IV, L.P. ("Venrock Entrepreneurs" and together with Venrock IV and Venrock Partners, the "Venrock Entities").
The sole general partner of Venrock IV is Venrock Management IV, LLC ("VM4"). The sole general partner of Venrock Partners is Venrock Partners Management, LLC ("VPM"). The sole general partner of Venrock Entrepreneurs is VEF Management IV, LLC ("VEFM4"). VM4, VPM and VEFM4 disclaim beneficial ownership over all shares held by the Venrock Entities, except to the extent of their indirect pecuniary interests therein. Anthony B. Evnin is a member of VM4, VPM and VEFM4 and as such, he may be deemed to have voting and investment power with respect to these shares. Dr. Evnin disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest therein.
/s/ Anthony B. Evnin
2013-09-25